Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pelthos Therapeutics (PTHS) Invested Capital (2024 - 2025)

Pelthos Therapeutics has reported Invested Capital over the past 2 years, most recently at $38.9 million for Q4 2025.

  • Quarterly results put Invested Capital at $38.9 million for Q4 2025, up 5991.06% from a year ago — trailing twelve months through Dec 2025 was $38.9 million (up 5991.06% YoY), and the annual figure for FY2025 was $38.9 million, up 5991.06%.
  • Invested Capital for Q4 2025 was $38.9 million at Pelthos Therapeutics, down from $58.3 million in the prior quarter.
  • Over the last five years, Invested Capital for PTHS hit a ceiling of $58.3 million in Q3 2025 and a floor of -$6.5 million in Q2 2025.